We are live on
!
Find out more
LP
Lexington Partners Portfolio holdings
AUM
$134M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$211M
AUM Growth
+$14.3M
(+7.3%)
Cap. Flow
-$503K
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
+$501K |
| 2 |
SWI
SolarWinds Corporation Common Stock
SWI
|
+$1.68K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 50.23% |
| 2 | Healthcare | 28.79% |
| 3 | Technology | 20.98% |
Similar funds
RA
SWM
SA
SA
GEH
BGI
MMCM
STFP
Lexington Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Lexington Partners held 4 positions worth $211M, up 7.3% from $196M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lexington Partners's Q2 2021 filing shows 1 reduced and 1 closed positions. The largest sale was Oyster Point Pharma, Inc. Common Stock, an estimated $501K.
By sector, the portfolio is most concentrated in Consumer Staples at 50% of assets, down from 53% a quarter earlier, followed by Healthcare and Technology.
- Lexington Partners's biggest Q2 2021 reduction was SolarWinds Corporation Common Stock, cutting an estimated $1.68K.
- Lexington Partners fully exited Oyster Point Pharma, Inc. Common Stock in Q2 2021, selling an estimated $501K.
- Lexington Partners's ten largest holdings make up 100% of its $211M portfolio in Q2 2021.
- Lexington Partners opened 0 new positions and closed 1 in Q2 2021.
- Lexington Partners's portfolio value rose 7.3% quarter-over-quarter to $211M.
Based on Lexington Partners's 13F filing for Q2 2021, filed 12 Aug 2021.